Turning Point Brands (TPB) is back in focus after cautious 2026 guidance and plans for heavier marketing and distribution spending in its nicotine pouch business, which signaled a temporary hit to profitability despite solid recent results.
See our latest analysis for Turning Point Brands.
The cautious 2026 outlook and heavier nicotine pouch investment came after a period of strong fundamentals, yet the share price has pulled back sharply. This includes a 7 day share price return of 14.4% and a 30 day share price return of 28.54%, in contrast to a 1 year total shareholder return of 59.31% and a very large 3 year total shareholder return that is more than 4x. This suggests recent momentum has cooled even as longer term holders still sit on sizeable gains.
If this pullback has you thinking about where capital might work harder, it could be a good moment to broaden your search and check out 20 top founder-led companies.
So with revenue and net income growing, guidance reined in, and the share price sharply lower from recent levels, is TPB now trading at an attractive entry point, or is the market already accounting for that future growth story?
Most Popular Narrative: 23.4% Undervalued
Turning Point Brands' most followed narrative puts fair value at $121.25, well above the last close of $92.88. This frames the recent pullback very differently to the headline guidance reset.
The company's ability to grow its premium brands in high margin niches (e.g., Stoker's MST and Zig Zag), while maintaining strong customer loyalty and executing pricing actions, even as legacy segments decline, underpins stable or improving net margins and cash generation through industry transitions.
Curious what kind of revenue lift, margin shift, and future earnings power have to line up to support that fair value gap, and what happens if they do not? The full narrative unpacks those assumptions in plain numbers.
Result: Fair Value of $121.25 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, those assumptions still run into real world friction, including heavier Modern Oral spending that could pressure margins and the risk of tighter nicotine regulation hitting future earnings power.
Find out about the key risks to this Turning Point Brands narrative.
Another View: Market Multiple Flags a Richer Price
Our DCF model suggests TPB is trading about 14.2% below estimated fair value at $108.24. However, the current P/E of 30.6x sits above the fair ratio of 26.2x and well above the global Tobacco average of 13.3x. So is this a genuine mispricing or simply a full price for fast forecasts?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
With sentiment clearly mixed, this is a good time to move fast, review the full picture yourself, and weigh both sides using 4 key rewards and 1 important warning sign.
Ready for more investment ideas?
If TPB has sharpened your thinking, do not stop here. Use the Simply Wall Street Screener to quickly spot other opportunities that might fit your goals.
- Target potential mispricings by scanning our list of 46 high quality undervalued stocks that pair solid fundamentals with prices that may not fully reflect them.
- Lock in income-focused ideas by reviewing a curated set of 14 dividend fortresses built around higher yields and business resilience.
- Secure more defensive candidates by filtering for 63 resilient stocks with low risk scores where balance sheets and risk scores take center stage.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com